Amsterdam was chosen Monday (Nov. 20) as the new seat of the European Medicines Agency in the wake of the United Kingdom's earlier vote to exit the European Union. The regulator will be moved to Amsterdam by March 30, 2019, at the latest, and the EMA's dealings with FDA don't appear to be affected. EMA has been upfront in its need to scale down some of its non-essential operations as it relocates, but it appears ongoing efforts to share certain...